Ueno Fine Chemicals Industry Ltd. Overview
| Field | Detail | Source / Fiscal reference |
|---|---|---|
| Legal name (Japanese) | 上野製薬株式会社 | Company website, corporate outline (2026) |
| Legal name (English) | UENO FINE CHEMICALS INDUSTRY, LTD. | Company website |
| Former names | Ueno Shoten (上野商店, sole proprietorship, 1918–1945); Ueno Seiyaku Kogyo K.K. (上野製薬工業株式会社, 1945–1955); renamed 上野製薬株式会社 in 1955 | Company history page |
| Founding | August 1918, by Masajiro Ueno (上野政次郎) | Company outline |
| Incorporation jurisdiction | Japan (Companies Act); registered head office in Chiyoda-ku, Tokyo since 2019 (previously Osaka) | Company history page (2019 entry) |
| Corporate Number | 1,120,001,077,363 | National Tax Agency registry via Compalyze |
| Headquarters (dual-HQ system) | Tokyo HQ: 2-5-6 Hirakawacho, Chiyoda-ku, Tokyo 102-0093. Osaka HQ: 2-4-8 Koraibashi, Chuo-ku, Osaka 541-8543 | Company office page |
| Stock exchange / ticker | None – unlisted | — |
| ISIN / CUSIP | Not applicable (no listed securities) | — |
| Share capital | ¥1,010 million | Company outline; FY2026 statutory notice |
| Fiscal year end | 31 May | Compalyze (statutory filings) |
| Employees (latest) | 298 (May 2026) | Company outline |
| Employees trend (social-insurance insured headcount proxy) | 304 (Oct 2025) → 299 (Jul 2026) → 296 (Oct 2026); –2.6% YoY | Compalyze (Japan Pension Service data) |
| Annual sales (latest) | ¥17,143 million (FY2026, year to May 2026) | Company outline |
| Net income (latest) | approx. ¥0.96 billion (FY2026) | Statutory notice via Compalyze |
| Total assets (latest) | approx. ¥22.0 billion (FY2026) | Statutory notice via Compalyze |
| Accounting auditor (会計監査人) | Required by law (large company); firm name not publicly disclosed | Companies Act requirement; not disclosed |
| Statutory auditor (監査役) | Jun Demizu (出水 順) | Company officer list (2026) |
| Market capitalization | Not applicable – not publicly disclosed (unlisted) | — |
| Website | https://www.ueno-fc.co.jp | — |
| Representative directors | Masaya Ueno – Representative Director, Chairman & CEO; Hiroya Ueno – Representative Director, President & COO (since 6 Aug 2026) | Company officer list / news |
| Overseas entities | Ueno Fine Chemicals Industry (USA), Inc. (New York); Ueno Fine Chemicals Industry (Thailand), Ltd. (Bangkok office; Bangpoo Industrial Estate plant) | Company outline / office page |
| Group sister company | Ueno Food Techno Industry, Ltd. (株式会社ウエノフードテクノ), spun off from the food division in 2016 | Company history page |
Ueno Fine Chemicals Industry is a 108-year-old, family-controlled Japanese specialty chemicals manufacturer whose franchise rests on a single proprietary process: the "UENO Process," a continuous industrial implementation of the Kolbe–Schmitt carboxylation reaction, developed after second-generation leader Ryuzo Ueno elucidated the reaction mechanism in 1961. The process yields high-purity aromatic hydroxycarboxylic acids – principally POB® (para-hydroxybenzoic acid) and BON6® (6-hydroxy-2-naphthoic acid) – which the company claims are supplied at world-leading share as monomers for liquid crystal polymers. Downstream, it converts these monomers into parabens (cosmetic, pharmaceutical and food preservatives), pigment intermediates (BON3®) and its own vertically integrated thermoplastic UENO LCP® engineering resin for fine-pitch connectors and electronics. It is therefore simultaneously a critical upstream supplier to, and a niche downstream competitor of, global LCP majors. With roughly ¥17bn in sales and about 300 employees, it is small in scale but strategically embedded in the electronics materials chain.
What the company does
Ueno Fine Chemicals Industry operates two business divisions that are explicitly designed to be organically linked:
-
Chemical Products Division (化学薬品事業) – Research, development, manufacture and sale of aromatic hydroxycarboxylic acids and their derivatives, produced primarily at the Yokkaichi Plant (Mie Prefecture). Key products are POB® and BON6® (LCP monomers), parabens (methyl-, ethyl-, propyl-, butyl-paraben and derivatives), BON3® (3-hydroxy-2-naphthoic acid, a dye and pigment intermediate), resin additives, and developmental ligands for porous coordination polymers / metal-organic frameworks (PCP/MOF).
-
LCP Division (LCP事業) – Polymerization of the company's own POB® and BON6® monomers into thermotropic liquid crystal polyester base resins, and compounding with glass fibre, minerals and other fillers into finished grades marketed as UENO LCP®, produced primarily at the Itami Plant (Hyogo Prefecture), with additional neat-resin capacity at Yokkaichi since 2021.
Company's own description (paraphrased from the latest website corporate pages, 2026)
The company describes itself as a comprehensive chemical manufacturer composed of two divisions – chemical products and LCP resins – that places particular emphasis on in-house R&D, operating under the policy of researching and developing novel substances with functional properties. It states that the chemical products business uses the continuous Kolbe–Schmitt "UENO Process" as its core technology to produce fine chemicals not made by other companies and supply them worldwide, while the LCP business leverages the company's position as a global LCP monomer producer to offer a proprietary, flame-retardant thermoplastic polymer covering high-flow, heat-resistant, high-strength and general-purpose grades. The corporate philosophy is "Creativity and Originality" (創意工夫). The chairman's message emphasizes a shift from a product-out to a market-in orientation, a strengthened sales and marketing function, global information gathering, and the provision of technical information alongside physical product.
Business model and revenue model
| Dimension | Characterization |
|---|---|
| Revenue model mix | Essentially 100% product sales (tonnage-based specialty chemicals and engineered resin). No subscription or licensing revenue is disclosed; technical service is bundled with product. Custom processing is listed by third-party profiles as a service but no revenue is disclosed. |
| Pricing model | Contract and spot pricing per kilogram/tonne, with periodic price revisions passed through to customers (UENO LCP® price revision notices published June 2021 and June 2024). |
| Value-chain position | Upstream-to-midstream: buys commodity aromatic feedstocks (phenol, 2-naphthol, CO2, alkali) → produces high-purity monomers (POB®, BON6®) → sells monomers to third-party LCP polymerizers and consumes part internally → polymerizes and compounds UENO LCP® → sells pellets to injection molders and electronics component makers. In the paraben chain it sells to cosmetic, pharmaceutical and food formulators, generally via distributors. |
| Customer types | (a) Global LCP resin producers (evidence: US customs records show shipments from Ueno to Ticona – Celanese's LCP manufacturing unit – at Grover, North Carolina, in February 2025 under organic chemicals HS chapter 29); (b) connector and electronic component makers and injection molders; (c) cosmetics, pharmaceutical and food manufacturers (parabens); (d) dye and pigment makers (BON3®); (e) thermal-paper and specialty-chemical producers (historically). |
| End-markets | Smartphones, PCs, air-conditioners and other consumer electronics; automotive electronics; films and encapsulants; cosmetics and personal care; pharmaceuticals; food preservation; dyes and pigments; nylon plasticizers; emerging MOF/PCP and bio-based monomer markets. |
Independent characterization
Analytically, Ueno is best understood as a process-technology monopoly-type niche player embedded inside an oligopolistic electronics-materials chain. Its moat is not scale – at roughly ¥17bn of sales it is a fraction of the size of the LCP majors it supplies – but the decades-old know-how to run Kolbe–Schmitt carboxylation continuously, purify the products to polymer grade, and do so with remote-controlled, automated plants. This creates two economic profiles under one roof:
The monomer business: behaves like a specialty intermediate franchise: high switching costs (polymer-grade purity is qualified into customers' LCP recipes), few credible global suppliers of BON6® in particular, and demand tied to global LCP volumes, which in turn track smartphone, PC and automotive connector cycles.
The UENO LCP® business: behaves like a sub-scale engineering-plastics compounder that competes against its own customers. Its advantage is captive monomer supply and molecular-design flexibility (it offers base resins from the low-melting 8000/8100 series to the high-heat 6000 series); its disadvantage is limited scale versus Polyplastics, Celanese, Sumitomo Chemical, Toray and fast-growing Chinese producers.
The FY2025 net loss (≈–¥0.88bn) followed by a FY2026 recovery (≈+¥0.96bn net income on 17% revenue growth) suggests high operating leverage and cyclical sensitivity to electronics demand and input costs – consistent with a capital-intensive continuous-process manufacturer with a thin equity cushion (equity ratio ≈14–18%).
Strategy
Stated strategic themes (from chairman's and president's message and corporate philosophy)
The company's stated strategy, as expressed in the joint message by the Chairman & CEO and President & COO on its website, can be summarized in six themes:
-
Defend the R&D-driven core: Continue as an R&D-oriented company built on "Creativity and Originality," prioritizing development and supply of high-quality, original products.
-
Organizational transformation for speed and globalization: Reform internal systems to cope with an era of globalization and speed.
-
From product-out to market-in: Strengthen marketing, sales organization and two-way customer communication; collect and analyze global market information to develop products customers and markets need.
-
Hardware plus software: Provide technical information and solutions along with physical products.
-
Compliance and CSR: Emphasize compliance domestically and abroad, environmental protection and social contribution.
-
Global relevance: The management philosophy states the aim to win in technology development, create unique products integrating the highest-level technologies, and establish a raison d'être in the global market as a global company.
Strategic initiatives in the last 24 months
| Initiative | Date | Description | Strategic intent |
|---|---|---|---|
| Leadership renewal | Aug 2024 – Aug 2026 | CEO/COO split; family succession to Hiroya Ueno | Generational transition; new-business orientation |
| New Business Development Office | Aug 2025 | Created and led by Hiroya Ueno | Diversify beyond LCP monomers and parabens |
| KX176 ultra-high-flow LCP | Aug 2025 | Industry-leading flowability with improved moldability for fine-pitch connectors | Capture miniaturization trend in smartphone and wearable connectors; productivity (long-run molding) |
| Technical thought leadership | 2023–2025 | Contributions to industry books and journals on LCP injection molding and LCP development | Brand building in Japanese molding community |
| CSR Policy | Sep 2025 | Nine-pillar policy: human rights/labour, health & safety, environment, fair trade/ethics, quality/safety, information management, social contribution, supply chain | Meet customer supply-chain audit requirements (electronics OEMs) |
| Basic Purchasing Policy | Mar 2026 | Fair, transparent purchasing with human rights, labour, environmental, quality and safety considerations | Sustainable supply-chain management |
| Job-seeker harassment prevention policy | Sep 2026 | Formal policy | Labour compliance; recruiting |
| Patent-backed new materials | 2023–2026 | Grants for FDCA production method, LCP compositions with improved film-forming, LCP fine-particle production, microcapsules; MOF ligand process patents | Bio-based polymers (FDCA → PEF), LCP films for high-frequency circuits, powders/coatings, new functional materials |
| Capacity: Yokkaichi LCP neat resin | 2021 (operational) | 1,250 t/yr | Second polymerization site; supply resilience |
Medium-term financial targets / guidance
Not publicly disclosed. The company has published no medium-term plan, revenue targets, margin targets, capex plans or cost programmes.
Products & Services
Chemical Products Division – core substances
| Product | Chemical identity / registry | Description and key capabilities | Target customers / applications | Launch year |
|---|---|---|---|---|
| POB® | p-Hydroxybenzoic acid; Japan existing chemical substance no. 3-1640 | Flagship UENO Process product; purified to polymer grade with proprietary refining; continuous production at Yokkaichi | Raw material for high-performance resins and fibres (LCP), and precursor for parabens and other chemicals | Continuous production from 1970; LCP-grade 6,000 t/yr plant 2001 |
| BON6® | 6-Hydroxy-2-naphthoic acid (HNA); no. 4-398 | Second flagship LCP monomer; naphthalene unit imparts processability and property balance in wholly aromatic LCPs | LCP and high-performance fibre producers worldwide | 1,980 |
The company states that POB® and BON6® are supplied globally and claims world-top market share in LCP monomers, stating that it delivers the world's highest quality through proprietary technology and stable supply.
Chemical Products Division – derivatives (current line)
| Product | Identity | Applications | Regulatory / registrations | Notes |
|---|---|---|---|---|
| Methylparaben (UENO Paraben) | Methyl p-hydroxybenzoate; no. 3-1585 | Fungicide/preservative for cosmetics, pharmaceuticals | Registered with JHOSPA (polyolefin hygiene council) and PVC hygiene council | Largest-volume paraben globally |
| Ethylparaben | Ethyl p-hydroxybenzoate | Preservative for cosmetics, pharmaceuticals, food | JHOSPA registered | Food-additive use permitted in Japan |
| Propylparaben | Propyl p-hydroxybenzoate | Preservative for cosmetics, pharmaceuticals, food | JHOSPA and PVC council registered | Subject to tighter EU cosmetic limits |
| Butylparaben | Butyl p-hydroxybenzoate | Preservative for cosmetics, pharmaceuticals, food | — | Subject to tighter EU cosmetic limits |
| 2-Ethylhexyl p-hydroxybenzoate | 2-EH ester of POB | Plasticizer for nylon resins | — | Industrial derivative |
UENO Paraben is positioned on cost-performance and stable quality and supply. The company maintains a dedicated consumer-facing paraben safety page (launched April 2015) and technical documents on antimicrobial efficacy and safety, signalling active defence of the paraben franchise against "paraben-free" marketing trends.
Chemical Products Division – development products
| Product | Identity / abbreviation | Intended applications | Status |
|---|---|---|---|
| 2,5-Dihydroxyterephthalic acid | DHTA; H4(dobdc); H4(dhtp) | Ligand for PCP/MOF; functional monomer | Small-volume new-substance notification filed under Japan's Chemical Substances Control Law |
| 4,4'-Dihydroxybiphenyl-3,3'-dicarboxylic acid | BPDC; H4(dobpdc) | Ligand for PCP/MOF; functional monomer | Small-volume notification filed; production-method patents filed 2023, latest US patent activity 2025 |
| Hexyl 4-hydroxybenzoate | NHPB; hexylparaben | Industrial preservative; insect repellent | Development |
| Hexadecyl 4-hydroxybenzoate | CEPB | Plasticizer; end-capping agent | Development |
Chemical Products Division – products with production track record
| Product | Identity | Applications | Notes |
|---|---|---|---|
| Sodium methylparaben | Sodium salt of methylparaben; no. 3-1613 | Cosmetic fungicide | Water-soluble form |
| Anisic acid | p-Methoxybenzoic acid; no. 3-1695 | Photographic chemicals; fragrance raw material | — |
| BON3® | 3-Hydroxy-2-naphthoic acid; no. 4-398 | Raw material and intermediate for dyes and pigments (notably red pigments) | Launched 1977; dust-free granulated form invented 1998, which the company calls a world first |
| β-Naphthol benzyl ether | no. 4-1458 | Sensitizer for thermal paper | — |
LCP Division – UENO LCP® portfolio
| Series / grade | Type | Key specifications / capabilities | Target applications | Launch year |
|---|---|---|---|---|
| UENO LCP® (original) | Thermotropic LCP | First commercial UENO LCP® | Electronics | 1,988 |
| 6000 series | High-flow, heat-resistant base resin | Highest heat resistance in the range | Heat-demanding electronic parts, SMT components | 1,999 |
| 8000 series | Low-melting base resin | A low-melting LCP type the company said did not previously exist in the market | Films, encapsulation/sealing | 2,003 |
| 8100 series | Low-melting base resin (lowest end of range) | Lowest melting point in lineup | Film, sealing, alloying | — |
| 3000 series | Connector-oriented base resin | Designed for fine-pitch connectors | Micro connectors | 2,011 |
| KX176 | Ultra-ultra-high-flow compound | Flow length at 0.1 mm thickness 19.6 mm (about 30% higher than comparison grade); zero drooling in 30 s nozzle test; tensile strength 110 MPa; elongation 3.2%; flexural strength 113 MPa; flexural modulus 6.4 GPa; DTUL 260°C at 0.46 MPa; good reflow resistance | Multi-contact, fine-pitch, low-profile connectors, e.g., board-to-board 4 rows × 160 pins × 0.175 mm pitch; FPC connectors 0.5 mm height × 26 pins × 0.15 mm pitch | 14 Aug 2025 |
| UM029 | High-flow connector compound (comparison grade) | Flow length 14.9 mm; drooling 0.2 g; tensile strength 157 MPa; flexural modulus 12.0 GPa; DTUL 273°C | Connectors requiring higher stiffness | — |
| UX207 | High-flow connector compound (comparison grade) | Flow length 11.4 mm; drooling 0.0 g; tensile strength 120 MPa; flexural modulus 9.0 GPa; DTUL 285°C | Connectors requiring higher heat resistance | — |
| Alloys / modifiers | LCP as modifier or alloy partner for other resins | Leverages LCP rheology and properties in blends | Other engineering plastics | Ongoing development |
Platform description: UENO LCP® is a thermotropic liquid crystal polyester developed in-house by a monomer producer. Base resins range from the low-melting 8100 series to the high-heat 6000 series, each compounded with glass fibre, minerals and other fillers into numerous grades. The company highlights ten core advantages: (1) excellent moldability with high flow and no flash; (2) dimensional stability through high modulus and low linear expansion; (3) solder heat resistance including lead-free solder; (4) very low outgassing; (5) vibration-damping characteristics despite high modulus; (6) electrical properties – withstand voltage and long-term durability; (7) low dielectric constant and dielectric loss, particularly in the GHz band; (8) inherent flame retardancy to UL-94 V-0 without flame retardants; (9) solvent resistance; (10) gas barrier against water vapour and gases.
KX176 figures are reference values, not guaranteed values, per the company's August 2025 product sheet. A full grade property table was published on 11 November 2020, and new and development grades were added to the online data collection in January, September and October 2021.
Pricing model: Not publicly disclosed; price revisions were requested from customers in June 2021 and June 2024.
Support model: Integrated technical, production and sales teams offering application support; patent filings since 2001 cover injection-molding methods and applications such as stator cores for hermetic motors.
Historical and divested product lines (for completeness)
| Line | Status | Detail |
|---|---|---|
| Food preservatives and additives (sorbic acid, protamine, oxygen absorbers, alcohol vapour agents, sugar alcohols, seasonings, pH adjusters, cleaning sanitizers, microbial testing) | Transferred to Ueno Food Techno Industry in 2016 | Historical brands include Mekkins (1935) and Solmighty® (1967) |
| Pharmaceuticals (ophthalmic Rescula®, trademarks Glauprost/Restila) | Transferred to R-Tech Ueno in 2001 | Company no longer handles pharmaceuticals |
| Veterinary drugs | Began 1960; current status not disclosed (presumed exited) | — |
| Phenacetin and other coal-tar chemicals | Historical (1938 onward) | — |
Trademark portfolio indicators
Registered marks visible in public IP databases include UENO TECROS and TECROS (registered 2017–2018 in industrial chemicals/insulating materials classes – product scope not publicly described), "UT" (2018), "エマルセーフ" (Emulsafe, registered 2026 in industrial chemicals and pharmaceuticals/supplements classes) and "こめ日和" (2015). Of roughly 130 trademark filings, 107 are live, concentrated in Class 1 (industrial chemicals).
Financial Narrative
Disclosure basis and limitations
Ueno does not publish annual reports, securities reports or investor presentations. The only financial data publicly available are (i) annual sales stated on the corporate website and (ii) summarized non-consolidated balance-sheet and income-statement figures from mandatory statutory financial notices (決算公告), aggregated by the Compalyze corporate database. These provide sales, net income, total assets, and derived ROE, ROA and equity ratio for FY2025 and FY2026.
Income statement (non-consolidated)
Sources: FY2026 revenue ¥17,143m per company outline (2026); FY2025 revenue ≈¥14.6bn, FY2025 net income ≈–¥0.88bn, FY2026 net income ≈¥0.96bn per statutory notices aggregated by Compalyze (rounded to ¥0.1bn or ¥0.01bn). Gross profit, operating income, EBITDA and pre-tax income: not publicly disclosed. EPS and DPS: not applicable / not publicly disclosed (unlisted; share count not disclosed). Revenue 5-year CAGR: cannot be computed – not publicly disclosed.
Balance sheet (non-consolidated)
Derivation: equity = total assets × equity ratio (FY2025: 21,700 × 14.13% ≈ 3,066; FY2026: 22,000 × 18.33% ≈ 4,033). Liabilities = total assets – equity. The ≈¥967m increase in derived equity between FY2025 and FY2026 reconciles closely to FY2026 net income of ≈¥960m, implying minimal or no dividend payout in FY2026 (analyst inference; dividend not disclosed). The short/long split of debt, cash, goodwill and working capital is not publicly disclosed.
Cash flow
All cash-flow items: not publicly disclosed (statutory notices for non-listed large companies require only balance sheet and income statement).
Ratios
ROE, ROA and equity ratio as computed by Compalyze from statutory notices. Asset turnover (derived) = revenue / average total assets for FY2026 (17,143 / 21,850); FY2025 uses year-end assets because FY2024 assets are not available (14,600 / 21,700). ROIC, current ratio, debt/equity (interest-bearing), net debt/EBITDA, interest coverage and cash conversion cycle: not publicly disclosed.
Trend commentary
Revenue. Sales rose 17.4% from ≈¥14.6bn in FY2025 to ¥17.14bn in FY2026. Management has not explained the drivers publicly. The most plausible contributors, in the analyst's assessment, are (i) a cyclical recovery in electronics demand, particularly smartphone and PC connector volumes, which drive both merchant monomer and UENO LCP® volumes; (ii) the full-year effect of the June 2024 UENO LCP® price revision; (iii) weaker yen boosting the yen value of export sales (the company is a significant exporter, evidenced by its New York subsidiary, Thai operations and US customs records); and (iv) new grades such as KX176 (launched August 2025) beginning to contribute. None of these drivers can be quantified from public data.
Profitability inflection. The swing from a ≈¥0.88bn net loss (–6.0% net margin) to ≈¥0.96bn net profit (+5.6%) on ≈¥2.5bn of incremental revenue implies an incremental net margin of roughly 73% on the revenue increase – far too high to be explained by operating leverage alone. This strongly suggests that FY2025 contained non-recurring charges (e.g., impairment of fixed assets, inventory write-downs, restructuring or extraordinary losses) and/or that FY2026 contained one-off gains, possibly related to management changes in August 2024. This is an inference; the company has not disclosed the composition of either year's result. A ROA of 4.35% in FY2026 is respectable for a Japanese specialty chemicals company of this size, but the ROE of 23.7% is flattered by the very thin equity base.
Balance-sheet strength. The equity ratio of 14.1% at May 2025 is low for a Japanese chemical manufacturer (listed specialty chemicals peers often run equity ratios of 50–70%). Derived liabilities of ≈¥18.6bn against ≈¥3.1bn of equity point to significant bank borrowing, likely financing the capital-intensive continuous plants (Yokkaichi POB® plant, 2021 Yokkaichi LCP neat-resin plant). The improvement to 18.3% in FY2026 was driven entirely by retained profit. The balance sheet is a key monitorable: a second loss year would erode equity quickly.
Scale and productivity. With 298 employees, FY2026 revenue per employee was ≈¥57.5m, which is high for Japanese chemicals, consistent with heavily automated, remote-controlled continuous plants as described by the company.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Division Overview
| Division | What it contains | Main products | Main plant | Responsible executive (2026) |
|---|---|---|---|---|
Chemical Products Division (化学薬品事業部) | Aromatic hydroxycarboxylic acids and derivatives made via the UENO Process | POB®, BON6®, parabens, BON3®, 2-ethylhexyl p-hydroxybenzoate, developmental MOF ligands (DHTA, BPDC), hexyl- and hexadecyl-parabens | Yokkaichi Plant (Mie) | Toshiyuki Ohashi, Executive Officer (Chemical Products) |
LCP Division (LCP事業部) | Thermotropic liquid crystal polyester base resins and compounds | UENO LCP® 6000, 3000, 8000/8100 series and compounded grades (e.g., KX176, UM029, UX207) | Itami Plant (Hyogo); additional neat resin at Yokkaichi | Shinji Ueno, Executive Officer (LCP & Business Administration) |
Corporate / R&D | Molecular design, process development, application development, IP | — | R&D Center (Sanda, Hyogo) | Ryoichi Otsuka and Satoshi Yonezawa, Executive Officers (IP & Technology Development) |
New Business Development | New business creation | Not disclosed (possibly linked to FDCA, MOF ligands, microcapsules per patent activity – analyst inference) | — | Hiroya Ueno, President & COO (oversight and new business) |
Segment revenue (JPY Mn)
| Segment revenue (JPY Mn) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Total company sales (JPY Mn) | — | 14,600 | 17,143 |
Segment operating income (JPY Mn) | FY2024 | FY2025 | FY2026 |
Income Statement and Margin Analysis (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
Revenue (JPY Mn) | 14,600 | 17,143 |
Net income (JPY Mn) | -880 | 960 |
Revenue growth YoY (%) (derived) | — | 17.4 |
Net margin (%) (derived) | -6.0 | 5.6 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansBalance Sheet and Margin Analysis (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
Total assets (JPY Mn) | 21,700 | 22,000 |
Equity ratio (%) | 14.13 | 18.33 |
Net assets / equity (JPY Mn) (derived) | 3,066 | 4,033 |
Total liabilities (JPY Mn) (derived) | 18,634 | 17,967 |
Share capital (JPY Mn) | 1,010 | 1,010 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansReturns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2025 | FY2026 |
|---|---|---|
ROE (%) | -28.52 | 23.74 |
ROA (%) | -4.03 | 4.35 |
Equity ratio (%) | 14.13 | 18.33 |
Asset turnover (x) (derived) | 0.67 | 0.79 |
Liabilities to equity (x) (derived) | 6.08 | 4.45 |
Financial leverage, assets/equity (x) (derived) | 7.08 | 5.46 |
Region revenue (JPY Mn)
| Region revenue (JPY Mn) | FY2025 | FY2026 |
|---|---|---|
Total (JPY Mn) | 14,600 | 17,143 |
Region Overview
| Region | Evidence of activity | Likely products sold | Assessment |
|---|---|---|---|
Japan | Dual HQs in Tokyo and Osaka; plants in Mie and Hyogo; domestic customers in electronics, cosmetics, pigments | All products | Home market and production base |
United States | Subsidiary Ueno Fine Chemicals Industry (USA), Inc., New York (est. 1981; NY branch from 1980); US customs records of shipments to Celanese's Ticona LCP plant in Grover, North Carolina (Feb 2025), classified under organic chemicals | POB®/BON6® monomers to LCP polymerizers; parabens | Strategic export market for monomers |
Thailand / ASEAN | Ueno Fine Chemicals Industry (Thailand), Ltd. (est. 1988; Bangpoo plant; Bangkok office); exhibits at Food Ingredients Asia; exports sorbitol to US blenders | Sweeteners (sorbitol and others), food preservation and sanitation products | Group's ASEAN food-ingredients base; consolidation relationship not disclosed |
China, Taiwan, Korea | Not explicitly disclosed, but the global LCP and connector supply chain is concentrated in East Asia, and market reports identify APAC as the largest LCP region | LCP monomers, UENO LCP®, parabens | Highly likely the largest export destination for LCP-related products (analyst inference) |
Europe | Not disclosed; company publishes English paraben technical materials | Parabens, monomers | Presence unconfirmed |
Capital Markets
| Item | Status |
|---|---|
Share price performance (1/3/5-year) | Not applicable – unlisted |
Valuation multiples (P/E, EV/EBITDA, EV/Sales, P/B) | Not applicable – unlisted |
Analyst consensus | None – no sell-side coverage |
Dividend history and policy | Not publicly disclosed; FY2026 equity build ≈ net income suggests no material payout in FY2026 (inference) |
Buyback authorizations | None disclosed |
Share capital | ¥1,010m |
Capital metric | FY2022 |
Analyst Conclusions
Management guidance and consensus
No management guidance and no consensus forecasts exist. The only forward-looking statements are qualitative: commitment to original high-quality products, market-in development, global information gathering, and compliance-led management.
Bull case
-
Monomer franchise leverage to LCP growth: With third-party forecasts of ≈7–8% annual LCP market growth and Ueno's claimed world-top share in POB®/BON6®, volume growth should accrue to Ueno regardless of which resin producer wins, as evidenced by its supply to Celanese.
-
Product-cycle tailwind in connectors: KX176's ≈30% flow improvement and zero-drooling performance address the most demanding fine-pitch connectors, which could lift mix and margins after a FY2026 revenue increase of 17.4%.
-
Option value in new materials: 2026 patent grants (FDCA, LCP film compositions, LCP fine particles, microcapsules) and MOF ligands could open higher-margin niches, now championed by a president who previously ran new business development.
Bear case
-
Fragile balance sheet: Equity ratios of 14–18% leave little cushion; a repeat of the FY2025 loss (≈¥0.88bn) would erase roughly a fifth of equity.
-
Commoditization pressure: Chinese LCP and monomer capacity growth, plus paraben market maturity (≈1% CAGR in conservative estimates), could compress pricing across both divisions.
-
Governance and execution risk: A three-person board without independent directors, rapid leadership turnover, and minimal disclosure make it hard for customers and lenders to assess continuity.
Catalysts and monitorables (next 12 months)
| Monitorable | Why it matters | Timing |
|---|---|---|
| FY2027 interim momentum (customer price notices, hiring) | Confirms whether FY2026 recovery is durable | Ongoing |
| FY2027 statutory notice (year to May 2027) | Sales vs ¥17.1bn; equity ratio vs 18.3% | ≈Aug 2027 |
| New strategy statements by President Hiroya Ueno | First articulation of new-business direction | Late 2026 – 2027 |
| KX176 adoption in smartphone/AI-server connectors | Mix and volume | 2026–2027 |
| Capacity announcements (monomer or LCP) | Signals confidence and financing ability | Any time |
| Paraben regulatory developments (EU, US states) | Demand for parabens | 2026–2027 |
| Further US customs data on monomer exports | Proxy for merchant monomer demand | Monthly |
| Commercialization of MOF ligands or FDCA | New revenue streams | Medium term |
Concluding analyst verdict
Ueno Fine Chemicals Industry is a textbook example of a Japanese "hidden champion": a small, family-controlled, process-technology company whose importance to a global industry is far larger than its ¥17bn revenue would suggest. Its continuous Kolbe–Schmitt UENO Process, refined over more than half a century and recognized with Japan's highest invention honours, underpins a claimed world-leading share in the POB® and BON6® monomers that wholly aromatic liquid crystal polymers depend on. Public trade data showing shipments to Celanese's LCP plant corroborate that this is not merely a marketing claim.
The investment-style question is not whether the franchise is real, but whether the company can monetize it more consistently. The evidence is mixed. FY2026 delivered a strong rebound – 17.4% revenue growth, ≈¥0.96bn net income and a 4.35% ROA – yet this followed a loss year, and the balance sheet remains thin, with an equity ratio of just 18.3%. The UENO LCP® resin business adds vertical-integration value and a credible product pipeline (notably KX176 for fine-pitch connectors), but it competes against far larger producers and against Ueno's own monomer customers. Parabens, the company's oldest franchise, face structural regulatory and consumer headwinds in Western markets.
Governance is the key swing factor. The August 2026 elevation of Hiroya Ueno, after a brief non-family presidency, signals a return to family stewardship with an explicit new-business mandate. Patent activity in FDCA, MOF ligands, LCP films and fine particles suggests real option value, but no strategy, targets or financial detail have been published.
Verdict: Strategically valuable, financially fragile, and opaque. For counterparties – customers, lenders, potential partners or acquirers – Ueno merits classification as a critical niche supplier with moderate credit risk, warranting close monitoring of annual statutory results, leadership communications and capacity decisions over the next 12–24 months.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Responsibilities | Tenure in role | Prior roles / background | Education / age |
|---|---|---|---|---|---|
Masaya Ueno (上野 昌也) | Representative Director, Chairman & CEO | Group leadership | Chairman since Aug 2024; joined 1991 | Fuji Bank (Apr 1988 – Mar 1991); joined Ueno Apr 1991; Director Aug 1992; Managing Director Jul 1997; Representative Director & President Nov 2003 – Aug 2024; Ueno Food Techno Representative Director & Chairman Jan 2016 – Apr 2021; Ueno Food Techno Director & Senior Advisor since Aug 2024 | Not publicly disclosed (≈mid-60s implied by 1988 bank entry – inference) |
Hiroya Ueno (上野 博也) | Representative Director, President & COO | Overall oversight; new business | President since 6 Aug 2026 | Joined Aug 2025 as Director and Head of New Business Development Office; Director & Executive Vice President Jan 2026 | Not publicly disclosed; prior career before 2025 not disclosed |
Yoshimitsu Nakano (中野 吉光) | Senior Managing Director | Finance | — | — | — |
Shinji Ueno (上野 進次) | Executive Officer | LCP business; business administration | — | — | — |
Toshiyuki Ohashi (大橋 俊之) | Executive Officer | Chemical Products business | — | — | — |
Ryoichi Otsuka (大塚 良一) | Executive Officer | IP; technology development | — | — | — |
Satoshi Yonezawa (米澤 智) | Executive Officer | IP; technology development | — | — | — |
Masayuki Deguchi (出口 将之) | Executive Officer | General affairs; HR; legal & compliance | — | — | — |
Hisanori Baba (馬場 久徳) | Executive Officer | Production control; environmental measures; logistics | — | — | — |
Jun Demizu (出水 順) | Statutory Auditor (Kansayaku) | Audit of directors' execution | — | — | — |
Toshizo Ido (井戸 敏三) | Advisor (顧問) | Advisory | Disclosed Nov 2023 | Former Governor of Hyogo Prefecture; awarded the Grand Cordon of the Order of the Rising Sun (announced Nov 2023) | — |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
8 Aug 2024 | Masaya Ueno: President → Representative Director, Chairman & CEO; Tomohito Iwasa appointed Director, President & COO | Leadership transition after 21 years of Masaya Ueno's presidency; coincided with FY2025, a loss-making year |
Aug 2024 | Masaya Ueno becomes Director & Senior Advisor of Ueno Food Techno | Group oversight |
Aug 2025 | Hiroya Ueno joins as Director, Head of New Business Development Office | Next generation enters |
28 Jan 2026 | Hiroya Ueno appointed Director & Executive Vice President | Succession step |
6 Aug 2026 | Hiroya Ueno appointed Representative Director, President & COO | Mr. Iwasa no longer listed among officers |
Major Shareholders
| Holder category | Stake | Source |
|---|---|---|
Ueno founding family and affiliates | Not publicly disclosed (presumed controlling) | Inference from leadership and private status |
Institutional owners (top 10) | Not applicable / not publicly disclosed | Unlisted |
Competitive Landscape
Competitors by Segment
| Business line | Competitor | Country | Relative positioning vs Ueno |
|---|---|---|---|
LCP resin | Polyplastics Co., Ltd. (Daicel group) – LAPEROS® LCP | Japan | Global volume leader in LCP; added 5,000 t/yr polymerization in Taiwan; far larger scale |
LCP resin | Celanese Corporation – Vectra®/Zenite® | USA | Pioneer and global leader; also a monomer customer of Ueno |
LCP resin | Sumitomo Chemical – SUMIKASUPER® LCP | Japan | ≈10,000 t/yr capacity (Ehime and group companies), studied a new plant of similar size; strong in smartphone connectors and low-dielectric grades |
LCP resin | Toray Industries – SIVERAS® | Japan | Integrated materials major; LCP film and resin |
LCP resin / film | Syensqo (ex-Solvay Specialty Polymers) – Xydar® | Belgium | High-heat LCP |
LCP resin | ENEOS (LCP business) | Japan | Domestic integrated producer |
LCP resin | Shanghai Pret Composites; Kingfa; Wotlon; Shanghai Xiangsheng | China | Rapidly expanding low-cost Chinese capacity; key pricing threat |
LCP film | Kuraray (Vecstar™); Murata | Japan | Film specialists; potential customers or competitors for Ueno's film-grade LCP |
LCP compounds | RTP Company; Avient (PolyOne); Chang Chun Group | USA / Taiwan | Compounders buying base resin |
LCP monomers (POB/HNA) | Chinese POB and HNA producers; Japanese and Indian p-hydroxybenzoic acid producers | China / India / Japan | Ueno claims world-top share; competitors primarily in POB, fewer in HNA |
Parabens | Clariant (Nipagin™ heritage, Nipaguard® blends); Gujarat Organics; Salicylates & Chemicals; Unicorn Petroleum Industries; multiple Chinese producers | Switzerland / India / China | Asian producers capturing growing share on price; Clariant positioned in blends and alternatives |
BON3 pigment intermediates | Chinese and Indian naphthol producers | China / India | Commodity-like competition; Ueno differentiates via dust-free granules |
Peer Comparison FY2026
| Company | Latest FY revenue | Revenue growth | Net margin | LCP relevance |
|---|---|---|---|---|
Ueno Fine Chemicals Industry (FY5/2026) | ¥17.1bn | +17.4% | ≈5.6% | Core (monomers + resin) |
Celanese Corp. (FY12/2024) | ≈US$10.3bn | — | — | LCP is a small part of Engineered Materials |
Sumitomo Chemical (FY3/2025) | ≈¥2.6tn | — | — | LCP within Advanced Materials |
Toray Industries (FY3/2025) | ≈¥2.6tn | — | — | LCP within resins/films |
Recent Developments
As a private company, Ueno issues few press releases.



